{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:13:44Z","timestamp":1766546024872,"version":"build-2065373602"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cld.2023.03.014","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T08:12:08Z","timestamp":1682496728000},"page":"717-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management of Portal Hypertension in Patients with Acute-on-Chronic Liver Disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Florence","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2023.03.014_bib1","doi-asserted-by":"crossref","first-page":"100316","DOI":"10.1016\/j.jhepr.2021.100316","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy","volume":"3","author":"Iwakiri","year":"2021","journal-title":"JHEP Rep"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2023.03.014_bib2","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jhep.2020.12.005","article-title":"Transition to decompensation and acute-on-chronic liver failure: role of predisposing factors and precipitating events","volume":"75","author":"Gustot","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17474124.2018.1481747","article-title":"Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications","volume":"12","author":"Ponziani","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2023.03.014_bib4","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation","volume":"75","author":"Trebicka","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-0035-1550430","article-title":"Rebalanced hemostasis in patients with acute liver failure","volume":"41","author":"Lisman","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cld.2023.03.014_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"CANONIC Study Investigators of the EASL-CLIF Consortium. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib7","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/hep.30220","article-title":"Comparison of therapies for primary prevention of esophageal variceal bleeding: a systematic review and network meta-analysis","volume":"69","author":"Sharma","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib8","first-page":"63","article-title":"Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis","volume":"25","author":"Bernard","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/apt.16156","article-title":"Non-selective beta-blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infection","volume":"53","author":"Sasso","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2023.03.014_bib10","article-title":"Beta-blockers in cirrhosis: evidence-based indications and limitations","volume":"2","author":"Rodrigues","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cld.2023.03.014_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/lt.24744","article-title":"Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates","volume":"23","author":"Kim","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2023.03.014_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jhep.2019.10.002","article-title":"Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation","volume":"72","author":"Giannelli","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib13","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of \u03b2-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cld.2023.03.014_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11901-022-00584-2","article-title":"Use of Non-selective beta blockers in decompensated cirrhosis and ACLF","volume":"21","author":"Gananandan","year":"2022","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.cld.2023.03.014_bib15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/liv.13119","article-title":"Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers","volume":"36","author":"Bang","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2023.03.014_bib16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.15439","article-title":"Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis","volume":"50","author":"Tergast","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2023.03.014_bib17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s12072-019-09986-9","article-title":"Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial","volume":"13","author":"Kumar","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cld.2023.03.014_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/lt.25678","article-title":"Precipitants of acute-on-chronic liver failure: an opportunity for preventative measures to improve outcomes","volume":"26","author":"Cullaro","year":"2020","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2023.03.014_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2020.04.024","article-title":"Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS","volume":"73","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib21","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"For early TIPS (Transjugular intrahepatic portosystemic shunt) Cooperative study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garc\u00eda-Pag\u00e1n","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2023.03.014_bib22","first-page":"1223","article-title":"Pre-emptive TIPSS in acute variceal bleeding: current status, controversies, and future directions","volume":"10","author":"Wong","year":"2022","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2214\/AJR.20.24811","article-title":"Commentary on: \" Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS","volume":"216","author":"Cornman-Homonoff","year":"2021","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.cld.2023.03.014_bib24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jhep.2020.05.001","article-title":"Pre-emptive TIPS for acute variceal bleeding in acute-on-chronic liver failure: is there enough evidence for a routine recommendation?","volume":"73","author":"Elhence","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib25","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/hep4.1963","article-title":"Patterns of kidney dysfunction in acute-on-chronic liver failure: relationship with kidney and patients' outcome","volume":"6","author":"Napoleone","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cld.2023.03.014_bib26","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.30494","article-title":"Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis","volume":"69","author":"Mahmud","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib27","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cld.2023.03.014_bib28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cld.2023.03.014_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.cld.2023.03.014_bib30","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2023.03.014_bib31","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jhep.2020.11.029","article-title":"The multifactorial mechanisms of bacterial infection in decompensated cirrhosis","volume":"75","author":"Van der Merwe","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib32","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.03.014_bib33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/gutjnl-2012-302339","article-title":"Bacterial infections in end-stage liver disease: current challenges and future directions","volume":"61","author":"Bajaj","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cld.2023.03.014_bib34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","article-title":"International Club of Ascites Global Study Group. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure","volume":"74","author":"Wong","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib35","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.14309\/ajg.0000000000000771","article-title":"The use of NACSELD and EASL-CLIF classification systems of ACLF in the prediction of prognosis in hospitalized patients with cirrhosis","volume":"115","author":"Cao","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.03.014_bib36","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/ajg.2014.212","article-title":"Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis","volume":"109","author":"Kim","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.03.014_bib37","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/hep.28330","article-title":"Antibiotic prophylaxis in cirrhosis: good and bad","volume":"63","author":"Fernandez","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib38","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib39","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.dld.2019.02.015","article-title":"Evaluating the best empirical antibiotic therapy in patients with acute-on-chronic liver failure and spontaneous bacterial peritonitis","volume":"51","author":"Wieser","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2023.03.014_bib40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30205","article-title":"Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy","volume":"70","author":"Anand","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib41","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/lt.24794","article-title":"Beta-blockers in patients with advanced liver disease: has the dust settled?","volume":"23","author":"Moctezuma-Velazquez","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2023.03.014_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.31012","article-title":"Grade 1 acute on chronic liver failure is a predictor for subsequent grade 3 failure","volume":"72","author":"Mahmud","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib44","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fern\u00e1ndez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.03.014_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12876-015-0389-9","article-title":"Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis","volume":"15","author":"Salerno","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cld.2023.03.014_bib47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2023.03.014_bib48","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-0676.2000.020001051.x","article-title":"Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients","volume":"20","author":"M\u00f8ller","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.cld.2023.03.014_bib51","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/00365520310008728","article-title":"Effect of terlipressin on blood volume distribution in patients with cirrhosis","volume":"39","author":"Kiszka-Kanewitz","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2023.03.014_bib52","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1572-0241.2004.40665.x","article-title":"Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in non-responders to the usual somatostatin dose","volume":"100","author":"Villanueva","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.03.014_bib53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cgh.2016.07.016","article-title":"Terlipressin improves renal function and reverses hepatorenal syndrome in patients with systemic inflammatory response syndrome","volume":"15","author":"Wong","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib54","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.03.014_bib55","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.03.014_bib56","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.03.014_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11938-020-00292-0","article-title":"Latest treatment of acute kidney injury in cirrhosis","volume":"18","author":"Wong","year":"2020","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.cld.2023.03.014_bib58","first-page":"1030A","volume":"64","author":"Boyer","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib59","doi-asserted-by":"crossref","first-page":"e0135625","DOI":"10.1371\/journal.pone.0135625","article-title":"Creatinine change on vasoconstrictors as mortality surrogate in hepatorenal syndrome: systematic review & meta-analysis","volume":"10","author":"Belcher","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2023.03.014_bib60","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/MEG.0b013e32833a4822","article-title":"Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis","volume":"22","author":"Krag","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib61","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib62","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/apt.17195","article-title":"Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure","volume":"56","author":"Wong","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2023.03.014_bib63","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/liv.15367","article-title":"Respiratory events with terlipressin and albumin in hepatorenal syndrome: a review and clinical guidance","volume":"42","author":"Allegretti","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2023.03.014_bib64","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/0885066619855021","article-title":"Acute respiratory distress syndrome: etiology, pathogenesis, and summary on management","volume":"35","author":"Kaku","year":"2020","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.cld.2023.03.014_bib65","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.03.014_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib68","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/apt.14052","article-title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies","volume":"45","author":"Sanyal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2023.03.014_bib69","article-title":"Practical management of HRS-AKI in the era of terlipressin: what the gastroenterologist needs to know","author":"Wong","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.03.014_bib70","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/apt.13912","article-title":"Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1","volume":"45","author":"Gilford","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2023.03.014_bib71","first-page":"CD013103","article-title":"Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis","volume":"9","author":"Best","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2023.03.014_bib72","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.03.014_bib73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.28250","article-title":"Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats","volume":"63","author":"Fern\u00e1ndez-Varo","year":"2016","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:31Z","timestamp":1761069571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1089326123000478"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.03.014","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Portal Hypertension in Patients with Acute-on-Chronic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}